Literature DB >> 3925877

In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.

W W Ng, P Y Chau, Y K Leung, D M Livermore.   

Abstract

The in vitro activities of Ro 17-2301 and aztreonam against 191 Pseudomonas aeruginosa isolates were compared with those of five other beta-lactam antibiotics. Both compounds showed activities comparable to that of ceftazidime and were bactericidal. They were as effective against gentamicin-or carbenicillin-resistant isolates as against susceptible ones.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3925877      PMCID： PMC180169          DOI： 10.1128/AAC.27.5.872

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  1 in total

1.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191
  1 in total
  7 in total

1.  In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.

Authors:  U Vurma-Rapp; F H Kayser
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

2.  Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.

Authors:  C A Benson; F E Walton; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

3.  Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.

Authors:  B R Smith; J L LeFrock; R V McCloskey; J B Donato; S J Weber; W S Joseph
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  In vitro activity of carumonam.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

5.  Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.

Authors:  A W Chow; J Wong; K H Bartlett; S D Shafran; H G Stiver
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 6.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Aztreonam concentration in abdominal tissues and bile.

Authors:  R E Condon; L T Friedhoff; C E Edmiston; B Levinson
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.